Obviously, I disagree with this approach. The stock was overbought, without news to support the price, and short sellers took advantage to make a profit. $5.68 is still nearly a double from 2 weeks ago and the company should be happy with that. There is nothing this interview, probably a paid interview, can accomplish besides giving more fuel to short sellers. I can’t imagine there’s much information NP can release right now that will recover the SP as many will hope.
At this point, only solid data and/or FDA approval will push the stock back up to, and past, the $10 level. Maybe we’ll get a PR tomorrow?
To be clear, I’m going to watch the video the second it’s released.